Dyadic International

Dyadic International

Biotechnology, 140 Intracoastal Pointe Dr Ste 404, Jupiter, Florida, 33477, United States, 1-10 Employees

dyadic.com

  • facebook
  • twitter
  • LinkedIn

Who is DYADIC INTERNATIONAL

Dyadic International, Inc. (Nasdaq: DYAI) - We are a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help bri...

Read More

map
  • 140 Intracoastal Pointe Dr Ste 404, Jupiter, Florida, 33477, United States Headquarters: 140 Intracoastal Pointe Dr Ste 404, Jupiter, Florida, 33477, United States
  • 1979 Date Founded: 1979
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 423920 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from DYADIC INTERNATIONAL

Dyadic International Org Chart and Mapping

Employees

Similar Companies to Dyadic International

Lykan Bioscience - Now RoslinCT

  • 201-500 201-500
  • 5 Million to 10 Million $ 5 Million to 10 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Dyadic International

Answer: Dyadic International's headquarters are located at 140 Intracoastal Pointe Dr Ste 404, Jupiter, Florida, 33477, United States

Answer: Dyadic International's official website is https://dyadic.com

Answer: Dyadic International's revenue is $5 Million to $10 Million

Answer: Dyadic International's SIC: 2836

Answer: Dyadic International's NAICS: 423920

Answer: Dyadic International has 1-10 employees

Answer: Dyadic International is in Biotechnology

Answer: Dyadic International top competitors include: Lykan Bioscience - Now RoslinCT

Answer: Dyadic International contact info: Phone number: Website: https://dyadic.com

Answer: Dyadic International, Inc. (Nasdaq: DYAI) - We are a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help bring biologic vaccines and drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers to improve access and cost to patients and the healthcare system - but most importantly to save lives.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access